Further diabetes reports indicate that the expert panel being consulted by the Food and Drug Administration in America is calling for potential diabetes drugs to be reviewed in terms of their heart risks before approval.
The advisory panel helping the FDA could cause a major change in legislation. The change could require drug manufacturers to change their diabetes trials, and potentially delay new drugs entering the market.
The concerns and change was prompted by major public outcry against diabetes drug Avandia, which reportedly increases risk of heart disease and death. The experts advising the FDA voted overwhelmingly for companies to do long-term cardiovascular studies.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…